en
Scientific article
English

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

Published inRheumatology, vol. 54, no. 9, p. 1664-1672
Publication date2015
Abstract

To determine the frequency of use of biologic DMARDs (bDMARDs) in monotherapy, to describe the baseline characteristics of patients treated with bDMARDs in monotherapy and to compare the effectiveness of bDMARDs in monotherapy with that of bDMARDs in combination with synthetic DMARDs (sDMARDs).

Keywords
  • Aged
  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/drug therapy/epidemiology
  • Biological Products/therapeutic use
  • Comorbidity
  • Disease Management
  • Drug Therapy, Combination
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Quality of Health Care
  • Registries
  • Retrospective Studies
  • Switzerland/epidemiology
  • Treatment Outcome
Citation (ISO format)
GABAY, Cem et al. Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry. In: Rheumatology, 2015, vol. 54, n° 9, p. 1664–1672. doi: 10.1093/rheumatology/kev019
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1462-0324
442views
0downloads

Technical informations

Creation31/08/2016 10:08:00
First validation31/08/2016 10:08:00
Update time15/03/2023 00:47:59
Status update15/03/2023 00:47:59
Last indexation16/01/2024 21:56:12
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack